Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/12/2026 | Q4 | $15.6B | -- | -- | $0.93 | -- |
| 10/30/2025 | Q3 | $15.2B | -- | -- | $0.95 | -- |
| 07/31/2025 | Q2 | $15.3B | -- | -- | $0.95 | -- |
| 05/08/2025 | Q1 | $13.8B | -- | -- | $0.73 | -- |
| 02/26/2025 | Q4 | $14.1B | -- | -- | $0.63 | -- |
| 10/31/2024 | Q3 | $15.7B | -- | -- | $0.91 | -- |
| 08/01/2024 | Q2 | $15.3B | $15.3B | $0.73 | $0.85 | -$0.12 |
| 05/08/2024 | Q1 | $14.4B | $14.5B | $0.54 | $0.66 | -$0.12 |
| 02/29/2024 | Q4 | $15.6B | $14.5B | $0.94 | $0.71 | $0.23 |
| 10/31/2023 | Q3 | -- | -- | $0.73 | $0.81 | -$0.08 |
| 08/03/2023 | Q2 | -- | -- | $0.17 | $0.69 | -$0.52 |
| 05/04/2023 | Q1 | -- | -- | $0.81 | $0.62 | $0.19 |
| 03/02/2023 | Q4 | -- | -- | $1.41 | $0.71 | $0.70 |
| 10/27/2022 | Q3 | -- | -- | $0.71 | $0.73 | -$0.02 |
| 07/28/2022 | Q2 | -- | -- | $0.79 | $0.72 | $0.07 |
| 05/05/2022 | Q1 | -- | -- | $0.05 | $0.60 | -$0.55 |
| 02/24/2022 | Q4 | -- | -- | $0.98 | $0.77 | $0.21 |
| 10/28/2021 | Q3 | -- | -- | $0.12 | $0.55 | -$0.43 |
| 07/29/2021 | Q2 | -- | -- | $0.94 | $0.91 | $0.03 |
| 05/06/2021 | Q1 | -- | -- | $0.30 | $0.52 | -$0.22 |
| 02/25/2021 | Q4 | -- | -- | $1.13 | $0.93 | $0.21 |
| 10/23/2020 | Q3 | -- | -- | $0.52 | $0.70 | -$0.18 |
| 07/30/2020 | Q2 | -- | -- | $0.18 | $0.28 | -$0.10 |
| 05/07/2020 | Q1 | -- | -- | -$1.15 | -$0.49 | -$0.66 |
| 02/27/2020 | Q4 | -- | -- | $0.06 | $0.62 | -$0.56 |
| 10/25/2019 | Q3 | -- | -- | $1.51 | $1.17 | $0.34 |
| 07/25/2019 | Q2 | -- | -- | $1.26 | $1.15 | $0.11 |
| 05/07/2019 | Q1 | -- | -- | $1.80 | $1.14 | $0.66 |
| 02/28/2019 | Q4 | -- | -- | $0.23 | $0.93 | -$0.70 |
| 10/25/2018 | Q3 | -- | -- | $0.49 | $1.15 | -$0.66 |
| 07/26/2018 | Q2 | -- | -- | $0.98 | -- | -- |
| 05/09/2018 | Q1 | -- | -- | $0.52 | -- | -- |
| 03/01/2018 | Q4 | -- | -- | -- | -- | -- |
| 10/26/2017 | Q3 | -- | -- | $1.04 | -- | -- |
| 07/27/2017 | Q2 | -- | -- | $0.77 | -- | -- |
| 05/04/2017 | Q1 | -- | -- | $0.71 | -- | -- |
| 03/02/2017 | Q4 | -- | -- | $0.21 | -- | -- |
| 10/28/2016 | Q3 | -- | -- | $0.34 | -- | -- |
| 07/29/2016 | Q2 | -- | -- | $0.09 | -- | -- |
| 05/04/2016 | Q1 | -- | -- | $0.08 | -- | -- |
| 02/25/2016 | Q4 | -- | -- | $1.40 | -- | -- |
Anheuser-Busch InBev NV reported $15.3B worth of top line sales in its most recent quarter.
Anheuser-Busch InBev NV announced earnings per share of $0.73 which represents a miss of analyst forecast a $0.85 per share.
Anheuser-Busch InBev NV reported $8.4B that represents $4.26 per share over the last quarter.
Anheuser-Busch InBev NV's earnings are forecast to grow from $2.86 per share to $3.33 per share next year representing an increase of 30.05%.
Anheuser-Busch InBev NV's next earnings date is February 12, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.